Last 47.15 INR
Change Today -0.25 / -0.53%
Volume 32.8K
BLIS On Other Exchanges
Symbol
Exchange
BLIS is not on other exchanges.
As of 4:35 AM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

bliss gvs pharma ltd (BLIS) Snapshot

Open
47.95
Previous Close
47.40
Day High
47.95
Day Low
46.85
52 Week High
07/7/14 - 54.95
52 Week Low
11/1/13 - 27.65
Market Cap
4.9B
Average Volume 10 Days
53.6K
EPS TTM
3.97
Shares Outstanding
103.1M
EX-Date
--
P/E TM
11.9x
Dividend
0.90
Dividend Yield
0.85%
Current Stock Chart for BLISS GVS PHARMA LTD (BLIS)

Related News

No related news articles were found.

bliss gvs pharma ltd (BLIS) Related Businessweek News

No Related Businessweek News Found

bliss gvs pharma ltd (BLIS) Details

Bliss GVS Pharma Limited engages in the manufacture and sale of branded generics, suppositories, soft pessaries, and women’s contraceptives in India and internationally. It offers prescription drugs, including antimalarial, anal suppositories, vaginal pessaries, and general products. The company also offers over the counter products, including Today, a vaginal contraceptive; and Maitri, a vaginal lubricant pessary. In addition, it offers pessary formulations, suppository formulations, calcium preparations, protein powders, iron preparations, antibiotics, analgesic and antipyretics, respiratory products, anti-inflammatory products, dermatological preparations, and anti-diarrhoeal products. Further, the company provides contract manufacturing services. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Founded in 1984

bliss gvs pharma ltd (BLIS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bliss gvs pharma ltd (BLIS) Key Developments

Bliss Gvs Pharma Limited Declares Final Dividend for the Year Ended March 31, 2014

Bliss Gvs Pharma Limited announced that in its board meeting held on May 26, 2014 declared final dividend of 50%, for the year ended March 31, 2014.

Bliss Gvs Pharma Limited Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2014 and Audited Consolidated Earnings Results for the Year Ended March 31, 2014

Bliss Gvs Pharma Limited reported unaudited standalone earnings results for the fourth quarter and year ended March 31, 2014 and audited consolidated earnings results for the year ended March 31, 2014. For the quarter, on standalone basis the company's net sales were INR 537.314 million compared to INR 1,001.271 million last year. Profit from operations before other income and finance cost and exceptional items was INR 54.288 million compared to INR 162.904 million last year. Profit form ordinary activities before tax INR 42.345 million compared to INR 213.973 million last year. Net profit after tax INR 15.145 million compared to INR 57.045 million last year. Basic and diluted EPS was INR 0.15 compared to INR 0.55 for the last year. For the year, on standalone basis the company's net sales were INR 2,834.925 million compared to INR 3,481.082 million last year. Profit from operations before other income and finance cost and exceptional items was INR 638.366 million compared to INR 963.542 million last year. Profit form ordinary activities before tax INR 822.984 million compared to INR 1,048.324 million last year. Net profit after tax INR 539.265 million compared to INR 566.821 million last year. Basic and diluted EPS was INR 5.23 compared to INR 5.50 for the last year. For the year, on consolidated basis the company's net sales were INR 3,397.326 million compared to INR 3,908.324 million last year. Profit from operations before other income and finance cost and exceptional items was INR 627.647 million compared to INR 1,051.310 million last year. Profit form ordinary activities before tax INR 705.582 million compared to INR 1,094.824 million last year. Net profit after tax INR 410.315 million compared to INR 595.845 million last year. Basic and diluted EPS was INR 3.97 compared to INR 5.60 for the last year.

Bliss Gvs Pharma Limited to Report Q4, 2014 Results on May 26, 2014

Bliss Gvs Pharma Limited announced that they will report Q4, 2014 results on May 26, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLIS:IN 47.15 INR -0.25

BLIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BLIS.
View Industry Companies
 

Industry Analysis

BLIS

Industry Average

Valuation BLIS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BLISS GVS PHARMA LTD, please visit www.blissgvspharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.